Iris Melanoma
Also known as: Malignant melanoma of iris (disorder)
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB06186 | Ipilimumab | 0 | Terminated | 1 |
| DB13076 | Yttrium Y-90 | 0 | Terminated | 1 |
| DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
| DB01073 | Fludarabine | 1 | Recruiting | 1 |
| DB14865 | Human interleukin-2 | 1 | Recruiting | 1 |
| DB08885 | Aflibercept | 2 | Completed | 1 |
| DB15018 | Agatolimod | 2 | Completed | 1 |
| DB11105 | Benzalkonium | 2 | Completed | 1 |
| DB00188 | Bortezomib | 2 | Completed | 1 |
| DB00958 | Carboplatin | 2 | Completed | 2 |
| DB04849 | Cediranib | 2 | Completed | 1 |
| DB05759 | Cixutumumab | 2 | Completed | 1 |
| DB12250 | Cixutumumab | 2 | Completed | 1 |
| DB00851 | Dacarbazine | 2 | Completed | 2 |
| DB14800 | GP-100 antigen | 2 | Completed | 2 |
| DB03366 | Imidazole | 2 | Completed | 1 |
| DB17475 | Incomplete Freund's adjuvant | 2 | Completed | 2 |
| DB00105 | Interferon alfa-2b | 2 | Completed | 1 |
| DB01229 | Paclitaxel | 2 | Completed | 2 |
| DB00020 | Sargramostim | 2 | Completed | 1 |
| DB11689 | Selumetinib | 2 | Completed | 1 |
| DB00398 | Sorafenib | 2 | Completed | 1 |
| DB00139 | Succinic acid | 2 | Active Not Recruiting | 1 |
| DB01268 | Sunitinib | 2 | Active Not Recruiting | 1 |
| DB00853 | Temozolomide | 2 | Completed | 1 |
| DB16626 | Tyrosinase | 2 | Completed | 2 |
| DB00313 | Valproic acid | 2 | Active Not Recruiting | 1 |
| DB02546 | Vorinostat | 2 | Completed | 1 |
| DB00020 | Sargramostim | 3 | Completed | 1 |
| DB16626 | Tyrosinase | 3 | Completed | 1 |